Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4120990-A4120990, November 12, 2024. Background:Recent advancements have seen deep learning models help differentiate echocardiography images of patients with heart failure with preserved ejection fraction (HFpEF) from normal controls.

Heart Failure 75

Heart Failure Preserved Ejection Fraction Circulation 75

Circulation

SEPTEMBER 10, 2024

Circulation, Ahead of Print. Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions.

Heart Failure 80

Heart Failure Kidney Disease Heart Transplant Transplant 80

Circulation

JANUARY 27, 2025

Circulation, Ahead of Print.

Heart Disease 81

Heart Disease Peripheral Arterial Disease Strokes Stroke 81

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

Background The relationship between ketone bodies (KB) and mortality in patients with heart failure (HF) syndrome has not been well established.

Heart Failure 64

Heart Failure Circulation 64

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Objectives In dyspneic patients with atrial fibrillation (AF) or obesity, the diagnostic performance of NT-proBNP for acute heart failure is reduced. In patients with AF, the AUC decreased for ERFE in each cohort (NZ: 0.71, n  = 105, SG: 0.61, n  = 44) but increased in patients with obesity (NZ: 0.79, n  = 150, SG: 0.87, n  = 164).

Heart Failure 59

Heart Failure Circulation Obesity Atrial Fibrillation 59

Circulation: Heart Failure

JANUARY 20, 2025

Circulation: Heart Failure, Ahead of Print. The integrative physiology of the left ventricle and systemic circulation is fundamental to our understanding of advanced heart failure and cardiogenic shock.

Cardiogenic Shock 40

Cardiogenic Shock Heart Failure Circulation Physiology 40

Becker's Hospital Review - Cardiology

AUGUST 14, 2024

Certain gut metabolites are linked to an increased risk of heart failure, according to a study published Aug. 9 in Circulation: Heart Failure , an American Heart Association journal.

Heart Failure 52

Heart Failure Circulation 52

Circulation

SEPTEMBER 28, 2024

Circulation, Volume 151, Issue 2 , Page 149-158, January 14, 2025. BACKGROUND:Patients with heart failure (HF) with mildly reduced or preserved ejection fraction face heightened long-term risks of morbidity and mortality. Baseline SGLT2i use was a prespecified subgroup.

Heart Failure 72

Heart Failure Preserved Ejection Fraction Outcomes Circulation 72

Journal of the American Heart Association

DECEMBER 24, 2024

BackgroundOral treatment with the exogenous ketone body 3hydroxybutyrate improves cardiac function in patients with heart failure with reduced ejection fraction, but ketosis is limited to 3 to 4 hours. Twelve patients with heart failure with reduced ejection fraction were included. L/min (95% CI, 0.71.1

Heart Failure 45

Heart Failure Circulation Cardiac Function Strokes 45

Medical Xpress - Cardiology

NOVEMBER 5, 2024

Dr. Sören Brandenburg have identified a protein that plays a central role in the heart's adaptation to increased stress. The results of the study were published in Circulation Research.

Heart Failure 89

Heart Failure Research Circulation 89

Circulation

DECEMBER 7, 2023

Circulation, Ahead of Print. BACKGROUND:Sodium-glucose cotransporter 2 inhibitors reduce the risk of worsening heart failure (HF) and cardiovascular death in patients with HF irrespective of left ventricular ejection fraction.

Preserved Ejection Fraction 84

Preserved Ejection Fraction Heart Failure Exercise Cardiomyopathy 84

Becker's Hospital Review - Cardiology

JANUARY 2, 2025

Some heart failure patients with artificial hearts have been able to regenerate heart muscle, potentially paving the way for future heart failure treatment options, according to a study published Nov. 21 in Circulation.

Artificial Heart 92

Artificial Heart Heart Failure Circulation 92

Circulation

OCTOBER 13, 2024

Circulation, Volume 150, Issue 16 , Page 1220-1222, October 15, 2024.

Atrial Fibrillation 81

Atrial Fibrillation Heart Failure Ablation Circulation 81

European Journal of Heart Failure

JANUARY 21, 2025

Our study aimed to evaluate whether circulating levels of growth differentiation factor-15 (GDF-15) could predict adverse changes in echocardiographic indexes of cardiac structure and function in an initially healthy populational familial cohort with a long follow-up (STANISLAS cohort).

Circulation 40

Circulation Blood Pressure Cholesterol Research 40

European Journal of Heart Failure

DECEMBER 22, 2023

The interaction between body mass index (BMI) and NT-proBNP with respect to heart failure (HF) risk remains incompletely defined. Hospitalization for heart failure (HHF) was examined across strata of baseline BMI and NT-proBNP. to 4.7%; p-trend = 0.059).

Heart Failure 75

Heart Failure BMI Obesity Article 75

Circulation: Heart Failure

JULY 9, 2024

Circulation: Heart Failure, Ahead of Print.

Cardiogenic Shock 75

Cardiogenic Shock Heart Failure Circulation 75

Circulation: Heart Failure

FEBRUARY 28, 2025

Circulation: Heart Failure, Ahead of Print. High out-of-pocket costs and financial toxicity related to heart failure treatment are substantial concerns. Furthermore, heart failure rarely occurs in isolation.

Heart Failure 40

Heart Failure Circulation 40

Circulation

DECEMBER 28, 2023

Circulation, Ahead of Print. BACKGROUND:Progressive remodeling of cardiac gene expression underlies decline in cardiac function, eventually leading to heart failure. Cardiomyocyte-specific overexpression ofIno80, its core catalytic subunit, induced heart failure within 4 days.

Heart Failure 53

Heart Failure Cardiac Function Circulation 53

DAIC

JUNE 24, 2024

Kittleson, director of Heart Failure Research and director of Post Graduate Medical Education in Heart Failure and Transplantation, is an associate editor specializing in heart failure. Levine Early Career Clinical Investigator Award from the American Heart Association.

Heart Failure 100

Heart Failure Transplant Interventional Cardiology Research 100

Circulation

MARCH 17, 2024

Circulation, Volume 149, Issue 12 , Page 899-901, March 19, 2024.

Heart Failure 67

Heart Failure Circulation 67

Circulation

APRIL 3, 2024

Circulation, Ahead of Print. Guideline-directed medical therapies and guideline-directed nonpharmacological therapies improve quality of life and survival in patients with heart failure (HF), but eligible patients, particularly women and individuals from underrepresented racial and ethnic groups, are often not treated with these therapies.

Heart Failure 58

Heart Failure Quality of Life Education Circulation 58

Journal of the American Heart Association

DECEMBER 8, 2023

BackgroundData on the use of implanted hemodynamic monitoring (IHM) in patients with Fontan circulation are limited. Heart failure hospitalizations/year were similar before and after IHM (median, 1 [interquartile range, 0–1.0] P=0.268), though only 46% of heart failure hospitalizations had associated IHM transmissions.

Circulation 49

Circulation Heart Failure Pulmonary Embolism 49

Medical Xpress - Cardiology

DECEMBER 21, 2024

A research team co-led by a physician-scientist at the University of Arizona College of MedicineTucson's Sarver Heart Center found that a subset of artificial heart patients can regenerate heart muscle, which may open the door to new ways to treat and perhaps someday cure heart failure.

Artificial Heart 89

Artificial Heart Heart Failure Circulation Research 89

MIBHS

OCTOBER 15, 2024

This is where coronary circulation comes into play. Coronary circulation refers to the movement of blood through the network of coronary arteries and veins that supply the heart muscle (myocardium) itself. Step-by-Step Breakdown of Coronary Circulation 1.

Circulation 52

Circulation Heart attacks Heart Attack Chest Pain 52

Cardiovascular Diabetology

OCTOBER 27, 2024

Diabetes mellitus (DM) is associated with premature atherosclerotic disease, coronary artery disease (CAD) and chronic heart failure (HF), leading to increased morbidity and mortality. Sodium-Glucose Co-transp.

Coronary Artery Disease 59

Coronary Artery Disease Diabetes Circulation Heart Failure 59

Heart BMJ

SEPTEMBER 25, 2024

We aimed to synthesise existing evidence on the observational and genetic associations between circulating proteins and CMD. Addition of protein biomarkers to traditional clinical models modestly improved the accuracy of predicting incident CMD, with the highest improvement for heart failure (C-index ~0.2).

Circulation 52

Circulation Biomarkers Heart Failure Atrial Fibrillation 52

Circulation

MAY 29, 2024

Circulation, Ahead of Print. With continued medical and surgical advancements, most children and adolescents with congenital heart disease are expected to survive to adulthood.

Congenital Heart Disease 45

Congenital Heart Disease Heart Failure Congenital Heart Disease 45

Circulation: Heart Failure

NOVEMBER 25, 2024

Circulation: Heart Failure, Volume 17, Issue 12 , Page e011629, December 1, 2024. Spironolactone, a steroidal mineralocorticoid receptor antagonist (MRA), has been used to treat patients with heart failure (HF) for more than half a century.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Myocardial Infarction Kidney Disease 40

Medical Xpress - Cardiology

SEPTEMBER 20, 2024

For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ventricular (LV) diastolic function, according to a study published online Sept. 9 in Circulation: Heart Failure.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Circulation 40

European Journal of Heart Failure

MARCH 11, 2025

Abstract Aims Sodiumglucose cotransporter 2 inhibitors (SGLT2i) improve cardiac performance and clinical outcomes in patients with heart failure, yet mechanisms underlying these beneficial effects remain incompletely understood. Empagliflozin treatment resulted in a twofold increase in circulating ketone bodies.

Heart Failure 40

Heart Failure Cardiac Function Myocardial Infarction Circulation 40

Circulation

MARCH 2, 2025

Circulation, Volume 151, Issue 9 , Page 585-588, March 4, 2025.

Heart Failure 45

Heart Failure Circulation 45

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4148170-A4148170, November 12, 2024. Background:Cardiovascular disease is an important cause for mortality in cancer patients and cancer is a primary cause of non- cardiac mortality in patients with heart failure. The primary outcome was 30-day all-cause hospital readmission.

Heart Failure 40

Heart Failure Cancer Hospital Outcomes 40

Circulation: Cardiovascular Quality & Outcomes

JANUARY 27, 2025

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

Heart Failure 56

Heart Failure Circulation Outcomes 56

Circulation: Cardiovascular Quality & Outcomes

NOVEMBER 20, 2024

Circulation: Cardiovascular Quality and Outcomes, Volume 17, Issue 12 , Page e011040, December 1, 2024. BACKGROUND:Posttraumatic stress disorder (PTSD) is associated with maladaptive dysregulation of stress response systems, which could lead to an increased risk of heart failure. 95% CI, 2.67.3). 95% CI, 2.16.3]).

Coronary Artery Disease 40

Coronary Artery Disease Heart Failure Hospital Myocardial Infarction 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144084-A4144084, November 12, 2024. It is primarily indicated for refractory angina that is not amenable to PCI or CABG with the opinion of a cardiologist.

Heart Transplant 75

Heart Transplant Transplant Angina Heart Failure 75

Circulation

JULY 28, 2024

Circulation, Volume 150, Issue 5 , Page 390-392, July 30, 2024.

Heart Failure 49

Heart Failure Biomarkers Circulation 49

Circulation

JANUARY 26, 2025

Circulation, Volume 151, Issue 4 , Page 348-350, January 28, 2025.

Heart Failure 45

Heart Failure Outcomes Circulation 45